BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30755274)

  • 1. Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial.
    Lois N; Gardner E; Waugh N; Azuara-Blanco A; Mistry H; McAuley D; Acharya N; Aslam TM; Bailey C; Chong V; Downey L; Eleftheriadis H; Fatum S; George S; Ghanchi F; Groppe M; Hamilton R; Menon G; Saad A; Sivaprasad S; Shiew M; Steel DH; Talks JS; Adams C; Campbell C; Mills M; Clarke M;
    Trials; 2019 Feb; 20(1):122. PubMed ID: 30755274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.
    Lois N; Campbell C; Waugh N; Azuara-Blanco A; Maredza M; Mistry H; McAuley D; Acharya N; Aslam TM; Bailey C; Chong V; Downey L; Eleftheriadis H; Fatum S; George S; Ghanchi F; Groppe M; Hamilton R; Menon G; Saad A; Sivaprasad S; Shiew M; Steel DH; Talks JS; Doherty P; McDowell C; Clarke M
    Health Technol Assess; 2022 Dec; 26(50):1-86. PubMed ID: 36541393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic Macular Edema and Diode Subthreshold Micropulse Laser: A Randomized Double-Masked Noninferiority Clinical Trial.
    Lois N; Campbell C; Waugh N; Azuara-Blanco A; Maredza M; Mistry H; McAuley D; Acharya N; Aslam TM; Bailey C; Chong V; Downey L; Eleftheriadis H; Fatum S; George S; Ghanchi F; Groppe M; Hamilton R; Menon G; Saad A; Sivaprasad S; Shiew M; Steel DH; Talks JS; Doherty P; McDowell C; Clarke M;
    Ophthalmology; 2023 Jan; 130(1):14-27. PubMed ID: 35973593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monotherapy laser photocoagulation for diabetic macular oedema.
    Jorge EC; Jorge EN; Botelho M; Farat JG; Virgili G; El Dib R
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010859. PubMed ID: 30320466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.
    Hykin P; Prevost AT; Sivaprasad S; Vasconcelos JC; Murphy C; Kelly J; Ramu J; Alshreef A; Flight L; Pennington R; Hounsome B; Lever E; Metry A; Poku E; Yang Y; Harding SP; Lotery A; Chakravarthy U; Brazier J
    Health Technol Assess; 2021 Jun; 25(38):1-196. PubMed ID: 34132192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthreshold micropulse laser versus standard laser for the treatment of central-involving diabetic macular oedema with central retinal thickness of <400ยต: a cost-effectiveness analysis from the DIAMONDS trial.
    Mistry H; Maredza M; Campbell C; Lois N;
    BMJ Open; 2023 Oct; 13(10):e067684. PubMed ID: 37852765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.
    Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E
    Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macular grid laser photocoagulation for branch retinal vein occlusion.
    Lam FC; Chia SN; Lee RM
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD008732. PubMed ID: 25961835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthreshold micropulse diode laser treatment in diabetic macular oedema.
    Laursen ML; Moeller F; Sander B; Sjoelie AK
    Br J Ophthalmol; 2004 Sep; 88(9):1173-9. PubMed ID: 15317711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUBTHRESHOLD MICROPULSE YELLOW LASER VERSUS SUBTHRESHOLD MICROPULSE INFRARED LASER IN CENTER-INVOLVING DIABETIC MACULAR EDEMA: Morphologic and Functional Safety.
    Vujosevic S; Martini F; Longhin E; Convento E; Cavarzeran F; Midena E
    Retina; 2015 Aug; 35(8):1594-603. PubMed ID: 25719988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
    Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007419. PubMed ID: 30325017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
    Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema.
    Figueira J; Khan J; Nunes S; Sivaprasad S; Rosa A; de Abreu JF; Cunha-Vaz JG; Chong NV
    Br J Ophthalmol; 2009 Oct; 93(10):1341-4. PubMed ID: 19054831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subthreshold yellow micropulse laser for treatment of diabetic macular edema: Comparison between fixed and variable treatment regimen.
    Donati MC; Murro V; Mucciolo DP; Giorgio D; Cinotti G; Virgili G; Rizzo S
    Eur J Ophthalmol; 2021 May; 31(3):1254-1260. PubMed ID: 32290705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUBTHRESHOLD MICROPULSE DIODE LASER VERSUS CONVENTIONAL LASER PHOTOCOAGULATION FOR DIABETIC MACULAR EDEMA: A Meta-Analysis of Randomized Controlled Trials.
    Chen G; Tzekov R; Li W; Jiang F; Mao S; Tong Y
    Retina; 2016 Nov; 36(11):2059-2065. PubMed ID: 27096529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Shalchi Z; Mahroo O; Bunce C; Mitry D
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009510. PubMed ID: 32633861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised clinical trial evaluating best-corrected visual acuity and central macular thickness after 532-nm subthreshold laser grid photocoagulation treatment in diabetic macular oedema.
    Pei-Pei W; Shi-Zhou H; Zhen T; Lin L; Ying L; Jiexiong O; Wen-Bo Z; Chen-Jin J
    Eye (Lond); 2015 Mar; 29(3):313-21; quiz 322. PubMed ID: 25697457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
    Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different settings for yellow subthreshold laser treatment in diabetic macular edema.
    Chhablani J; Alshareef R; Kim DT; Narayanan R; Goud A; Mathai A
    BMC Ophthalmol; 2018 Jul; 18(1):168. PubMed ID: 29996798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of micropulse laser combined with ranibizumab in diabetic macular edema treatment: study protocol for a randomized controlled trial.
    Mi X; Gu X; Yu X
    Trials; 2022 Sep; 23(1):736. PubMed ID: 36056443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.